183
Participants
Start Date
April 15, 2021
Primary Completion Date
December 20, 2022
Study Completion Date
April 13, 2023
Tezepelumab Dose 1
Subcutaneous injection.
Tezepelumab Dose 2
Subcutaneous injection.
Omalizumab
Subcutaneous injection.
Placebo
Subcutaneous injection.
Icahn School of Medicine at Mount Sinai, New York
Azienda Ospedaliera Citta della Salute e della Scienza di Torino, Torino
Laiko General Hospital of Athens, Athens
Sotiria General Hospital, Athens
*Charité*, Berlin
Attikon University General Hospital of Athens, Athens
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do
Andreas Syggros Hospital, Athens
Ajou University Hospital, Suwon-si, Gyeonggi-do
Hallym University Dongtan Sacred Heart Hospital, Hwaseong-si, Gyeonggi-do
IRCCS Istituto Clinico Humanitas, Rozzano MI
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan
Johns Hopkins Asthma and Allergy Center, Baltimore
Centre Hospitalier Universitaire de Brest - Hôpital Morvan, Brest
Advanced Medical Research PC, Sandy Springs
The Community Research of South Florida, Miami Lakes
Hôpital Saint Eloi, Montpellier
Clinical Research Center of Alabama, Birmingham
The Allergy Asthma and Sinus Center, East Tennessee Center for Clinical Research, Knoxville
Centre Hospitalier Universitaire de Grenoble - Hopital Nord Michallon, Grenoble
Family Allergy and Asthma Research Institute, Louisville
Bluegrass Allergy Care, Lexington
Azienda Ospedaliero Universitaria di Modena, Modena
Aventiv Research Inc, Dublin
Bernstein Clinical Research Center LLC, Cincinnati
Hospital General Universitario de Valencia, Valencia
Hospital Arnau de Vilanova de Valencia, Valencia
Dawes Fretzin Clinical Research Group, LLC, Indianapolis
David Fivenson MD Professional Liability Company, Ann Arbor
Henry Ford Medical Center - New Center One, Detroit
Clarkston Skin Research, Clarkston
Johannes Gutenberg Universitaet Mainz, Mainz
George Papageorgiou General Hospital of Thessaloniki, Thessaloniki
Washington University School of Medicine, St Louis
Epiphany Dermatology of Kansas, LLC, Overland Park
Centre Hospitalier Lyon Sud, Pierre-Bénite
Suzanne Bruce and Associates, Houston
Cutis Wellness Dermatology and Dermatopathology, PLLC, Laredo
Asthma and Allergy Associates PC, Colorado Springs
Jonathan Corren MD Inc, Los Angeles
Dermatology Research Associates, Los Angeles
Clinical Science Institute, Santa Monica
Avance Clinical Trials, Laguna Niguel
First OC Dermatology, Fountain Valley
Clinical Partners LLC, Johnston
Dermatology Research Institute Incorporated, Calgary
Brunswick Dermatology Centre, Fredericton
LEADER Research, Hamilton
Lynderm Research Inc, Markham
Cheema Research Incorporated, Mississauga
Dr. S. K. Siddha Medicine Professional Corporation, Newmarket
Allergy Research Canada Incorporated, Niagara Falls
Gordon Sussman Clinical Research Incorporated, North York
Clinique Spécialisée en Allergie de la Capitale, Québec
Centre Hospitalier Universitaire Archet 2, Nice
Universitaetsklinikum Dresden, Dresden
Fondazione Policlinico Tor Vergata, Roma
Policlinico Universitario Agostino Gemelli, Roma
Fujita Health University Bantane Hospital, Nagoya
Hiroshima University Hospital, Hiroshima
Takagi Dermatological Clinic, Obihiro-shi
Kosugi Dermatology Clinic, Kawasaki-shi
Nomura Dermatology Clinic, Yokohama
Osaka Habikino Medical Center, Habikino-shi
Dermatology and Ophthalmology Kume Clinic, Sakai-shi
Nihon University Itabashi Hospital, Itabashi-ku
NTT Medical Center Tokyo, Shinagawa-ku
Uniwersyteckie Centrum Kliniczne, Gdansk
AMICARE z ograniczona odpowiedzialnoscia spolka komandytowa, Lodz
SPZOZ Centralny Szpital Kliniczny, Lodz
Samodzielny Publiczny Szpital Kliniczny nr 1 w Lublinie, Lublin
Clinical Research Center Spzoo Medic-R Spolka Komandytowa, Poznan
Kliniczny Szpital Wojewodzki nr 1 im Fryderyka Chopina, Rzeszów
Klinika Osipowicz and Turkowski Spzoo Opieka Wielospecjalistyczna Osipowicz and Turkowski, Warsaw
Wojskowy Instytut Medyczny, Warsaw
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Hallym University Kangnam Sacred Heart Hospital, Seoul
Hospital del Mar, Barcelona
Hospital de la Santa Creu i Sant Pau, Barcelona
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Lead Sponsor
Amgen
INDUSTRY